(Q46753802)

English

Everolimus for refractory Crohn's disease: a case report

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Everolimus for refractory Crohn's disease: a case report (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Crohn's disease

1 reference

based on heuristic

inferred from title

author name string

Jérôme Dumortier

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Marie-George Lapalus

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Olivier Guillaud

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Gilles Poncet

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Marie-Claude Gagnieu

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Christian Partensky

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Jean-Yves Scoazec

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

14

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

874-877

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

Review article: Infliximab therapy for inflammatory bowel disease--seven years on

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Cyclosporine, tacrolimus, and mycophenolate mofetil in the treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

mTOR inhibitors: an overview

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Is there a role for proliferation signal/mTOR inhibitors in the prevention and treatment of de novo malignancies after heart transplantation? Lessons learned from renal transplantation and oncology

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

A controlled trial of azathioprine in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

A controlled double blind study of azathioprine in the management of Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Optimizing immunomodulator therapy for inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Tacrolimus: a further update of its use in the management of organ transplantation

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

How effective are the usual treatments for Crohn's disease?

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2FIBD.20395

21 January 2018

Identifiers

10.1002/IBD.20395

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18275074

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46753802&oldid=2129877448"